Both GIPR knockout mice and GIP over‐expressing mice are protected from high‐fat diet–induced obesity,1, 2, 3, 4, 5 and both GIPR agonists and GIPR antagonists induce moderate weight loss in preclinical obesity models.6, 7, 8. Here, GIPR is linked to obesity disorder.